Checkpoint Inhibitors and Urothelial Carcinoma: The Translational Paradigm
Published: | Updated:
The emergence of immune checkpoint inhibitors as effective cancer immunotherapy has effectively built a new “highway” connecting the promise of oncologic translational research to progress in treating advanced malignancies.